06855.HK
Ascentage Pharma Group International
HKSE · Healthcare · Biotechnology · CN
HKD 35.00
+1.74%Margins
Gross margin
85.1%
EBITDA margin
-229.1%
EBIT margin
-244.7%
Net margin
-254.6%
FCF margin
-158.0%
-468.4%
Return on equity
-80.4%
Return on assets
-94.5%
Return on invested capital
0.28x
Asset turnover
-HKD 1.8B
Cash from operations
HKD 6.20
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026